120 73.5 /H110063.7 23.8 /H110063.6 180 82.8 /H110065.0 25.8 /H110063.0 300 55.6 /H110063.7 52.3 /H110063.3 The AC2993 dose was administered at t /H110050 min, and the meal and acetaminophen were administered at t /H1100515 min. FIG. 4. A, Mean ( /H11001SEM) postprandial plasma glucagon concentration profiles following a single dose of placebo ( F)o r0 . 1 /H9262g/kg AC2993 ( E) o nd5( n /H1100520). B, Mean ( /H11001SEM) fasting plasma glucagon concentra- tion profiles following a single dose of placebo ( F), 0.05 /H9262g/kg AC2993 (E), 0.1/H9262g/kg AC2993 ( /H12135), or 0.2 /H9262g/kg AC2993 ( Å’)o nd5( n /H1100512). Conversion factor: ng/liter /H11005pg/ml. FIG. 5. Mean ( /H11001SEM) fasting plasma glucose (A) and serum insulin (B) concentration profile during th e 8 h following a single dose of placebo ( F), 0.05 /H9262g/kg AC2993 ( E), 0.1/H9262g/kg AC2993 ( f), or 0.2 /H9262g/kg AC2993 ( /H18554) administered at t /H110050( n/H1100512). Conversion factors: